biostudies-literatureUnknown14Rahman A<h4>Study objective</h4>To compare the characteristics and outcomes of COVID-19 patients with a hyperdynamic LVEF (HDLVEF) to those with a normal or reduced LVEF.<h4>Design</h4>Retrospective study.<h4>Setting</h4>Rush University Medical Center.<h4>Participants</h4>Of the 1682 adult patients hospitalized with COVID-19, 419 had a transthoracic echocardiogram (TTE) during admission and met study inclusion criteria.<h4>Interventions</h4>Participants were divided into reduced (LVEF < 50%), normal (≥50% and <70%), and hyperdynamic (≥70%) LVEF groups.<h4>Main outcome measures</h4>LVEF was assessed as a predictor of 60-day mortality. Logistic regression was used to adjust for age and BMI.<h4>Results</h4>There was no difference in 60-day mortality between patients in the reduced LVEF and normal LVEAmerican heart journal plus : cardiology research and practice100134https://www.ebi.ac.uk/biostudies/studies/S-EPMC9013697biostudies-literatureHyperdynamic left ventricular ejection fraction is associated with higher mortality in COVID-19 patients.PMC9013697Rahman ARuge MNair GHlepas AFugar SSuboc TVolgman ASGomez Jdu Fay de Lavallaz JRao AMarinescu KJahan NWilliams KAfalseHyperdynamic left ventricular ejection fraction is associated with higher mortality in COVID-19 patients.<h4>Study objective</h4>To compare the characteristics and outcomes of COVID-19 patients with a hyperdynamic LVEF (HDLVEF) to those with a normal or reduced LVEF.<h4>Design</h4>Retrospective study.<h4>Setting</h4>Rush University Medical Center.<h4>Participants</h4>Of the 1682 adult patients hospitalized with COVID-19, 419 had a transthoracic echocardiogram (TTE) during admission and met study inclusion criteria.<h4>Interventions</h4>Participants were divided into reduced (LVEF < 50%), normal (≥50% and <70%), and hyperdynamic (≥70%) LVEF groups.<h4>Main outcome measures</h4>LVEF was assessed as a predictor of 60-day mortality. Logistic regression was used to adjust for age and BMI.<h4>Results</h4>There was no difference in 60-day mortality between patients in the reduced LVEF and normal LVE2022-01-01T00:00:00Z2022 Feb2026-07-16T03:42:08.588Z2025-04-04T20:36:53.244ZS-EPMC90136973546319710.1016/j.ahjo.2022.100134